Association between chronic fatigue syndrome and the corticosteroid-binding globulin Gene ALA SER224 polymorphism

Endocrine Research

Volumn 30, Issue 3, 2004, Pages 417-429

  Torpy, David J ^a,e   Bachmann, A W ^a   Gartside, M ^a   Grice, J E ^a   Harris, J M ^b   Clifton, P ^c   Easteal, S ^d   Jackson, R V ^a   Whitworth, J A ^d  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^c CSIRO   (Australia)

^d Biology and Environment   (Australia)

^e ROYAL ADELAIDE HOSPITAL   (Australia)

Author keywords

Chronic fatigue syndrome; Corticosteroid binding globulin; Genetic association study; Hydrocortisone

Indexed keywords

ALANINE; HYDROCORTISONE; LEUKOCYTE ELASTASE; SERINE; TRANSCORTIN;

ADULT; ALLELE; ARTICLE; CHRONIC FATIGUE SYNDROME; CONTROLLED STUDY; DISEASE DURATION; DISEASE EXACERBATION; DNA POLYMORPHISM; EXON; FEMALE; GENE MUTATION; GENE SEQUENCE; GENETIC CODE; GENETIC RISK; HOMOZYGOSITY; HORMONE TRANSPORT; HUMAN; HUMAN CELL; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNOREACTIVITY; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; RADIOIMMUNOASSAY; RESTRICTION MAPPING;

ADULT; AMINO ACID SUBSTITUTION; FATIGUE SYNDROME, CHRONIC; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HOMOZYGOTE; HUMANS; HYDROCORTISONE; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; REFERENCE VALUES; TRANSCORTIN;

EID: 7544220619     PISSN: 07435800     EISSN: None     Source Type: Journal    
DOI: 10.1081/ERC-200035599     Document Type: Article

References (32)

1. Steele L, Dobbins JG, Fukuda K, Reyes M, Randall B, Koppelman M, Reeves WC. The epidemiology of chronic fatigue in San Francisco. Am J Med 1998; 105:838-90S.
2. Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, Komaroff A. The chronic fatigue syndrome: a comprehensive approach to its definition and study. Ann Intern Med 1994; 121:953-959.
3. Demitrack MA, Dale JK, Straus SE, Laue L, Listwak SJ, Kruesi MJ, Chrousos GP, Gold PW. Evidence for impaired activation of the hypothalamic-pituitary- adrenal axis in patients with chronic fatigue syndrome. J Clin Endocrinol Metab 1991; 73:1224-1234.
4. Cleare AJ, Heap E, Malhi GS, Wessely S, O'Keane V, Miell J. Low-dose hydrocortisone in chronic fatigue syndrome: a randomized crossover trial. Lancet 1999; 353:455-458.
5. Clauw DJ, Chrousos GP. Chronic pain and fatigue syndromes: overlapping clinical and neuroendocrine features and potential pathogenic mechanisms. Neuroimmuno-modulation 1997; 4:134-153.
6. Hickie I, Kirk K, Martin N. Unique genetic and environmental determinants of prolonged fatigue: a twin study. Psychol Med 1999; 29:259-268.
7. Hickie I, Bennett B, Lloyd A, Heath A, Martin N. Complex genetic and environmental relationships between psychological distress, fatigue and immune function: a twin study. Psychol Med 1999; 29:269-277.
8. Buchwald D, Herrell R, Ashton S, Belcourt M, Schmaling K, Sullivan P, Neale M, Goldberg J. A twin study of chronic fatigue. Psychosom Med 2001; 63:936-943.
9. Walsh CM, Zainal NZ, Middleton SJ, Paykel ES. A family history study of chronic fatigue syndrome. Psychiatr Genet 2001; 11:123-128.
10. Torpy DJ, Bachmann AW, Grice JE, Fitzgerald SP, Phillips PJ, Whitworth JA, Jackson RV. Familial corticosteroid-binding globulin deficiency due to a novel null mutation: association with fatigue and hypotension. J Clin Endocrinol Metab 2001; 86:3692-3700.
11. Emptoz-Bonneton A, Cousin P, Seguchi K, Avvakumov GV, Bully C, Hammond GL, Pugeat M. Novel human corticosteroid-binding globulin variant with low cortisol-binding affinity. J Clin Endocrinol Metab 2000; 85:361-367.
12. Baima J, Viera JG, Abucham J. Hereditary corticosteroid-binding deficiency. Proc 77th Ann Sci Mtg Endoc Soc, Washington DC, 1995. Poster 353.
13. Brunner E, Baima J, Vieira T, Vieira JH, Abucham J. Molecular characterization of corticosteroid-binding globulin (CBG) deficiency in a Brazilian kindred. Proc 83rd Ann Sci Mtg Endoc Soc, Denver, Colorado, 2001. Poster P1-404.
14. Tsigos C, Kyrou I, Chrousos GP, Papanicolaou DA. Prolonged suppression of corticosteroid-binding globulin by recombinant human interleukin-6 in man. J Clin Endocrinol Metab 1998; 83:3379.
15. Bernier J, Jobin N, Emptoz-Benneton A, Pugeat MM, Garrel DR. Decreased corticosteroid-binding globulin in burn patients: relationship with interleukin-6 and fat in nutritional support. Crit Care Med 1998; 26:452-460.
16. Zouaghi H, Savu L, Delarme J, Kleinknecht D, Nunez EA. Loss of serum transcortin in human shock associated with severe infection by Candida albicans. Acta Endocrinol (Copenh) 1983; 102:277-281.
17. Vogeser M, Felbinger TW, Kilger E, Roll W, Fraunberger P, Jacob K. Corticosteroid-binding globulin and free cortisol in the early postoperative period after cardiac surgery. Clin Biochem 1999; 32:213-216.
18. Tinnikov AA, Legan MV, Sheveluk NA, Cvetaskaya GA, Navibenko SE, Sidelnikov SG. Corticosteroid and immune responses to cardiac surgery. Steroids 1996; 61:411-415.
19. Emptoz-Bonneton A, Crave JC, LeJeune H, Brebant C, Pugeat M. Corticosteroid-binding globulin synthesis regulation by cytokines and glucocorticoids in human hepatoblastoma-derived (HepG2) cells. J Clin Endocrinol Metab 1997; 82:3758-3762.
20. Pemberton PA, Stein PE, Pepys MB, Potter JM, Carrell RW. Hormone binding globulins undergo serpin conformational change in inflammation. Nature 1988; 336:257-258.
21. Demettre E, Bastide L, D'Haese A, De Smet K, De Meirleir K, Tiev KP, Englebienne P, Lebleu B. Ribonuclease L proteolysis in peripheral blood mononuclear cells of chronic fatigue syndrome patients. J Biol Chem 2002; 277:35746-35751.
22. Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 1989; 46:1121-1123.
23. Smith CL, Power SGA, Hammond GL. A Leu-His substitution at residue 93 in human corticosteroid binding globulin results in reduced affinity for cortisol. J Steroid Biochem Mol Biol 1992; 42:671-676.
24. Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci 1977; 74:5463-5467.
25. Al-Hakiem MH, Abbas SJ. Simple adaptation of a radioimmunoassay kit for serum cortisol used to measure salivary cortisol. Clin Chem 1987; 33:191.
26. Coolens JL, Van Baelen H, Heyns W. Clinical use of unbound plasma cortisol as calculated from total cortisol and corticosteroid-binding globulin. J Steroid Biochem 1987; 26:197-202.
27. Savu L, Zouaghi H, Corli A, Nunez EA. Serum depletion of corticosteroid binding activities, an early marker of human septic shock. Biochem Biophys Res Commun 1981; 102:411-414.
28. Schlechte JA, Hamilton D. The effect of glucocorticoids on corticosteroid binding globulin. Clin Endocrinol (Oxf) 1987; 27:197-203.
29. Cole TJ, Harris HJ, Hoong I, Solomon N, Smith R, Krozowski Z, Fullerton MJ. The glucocorticoid receptor is essential for maintaining basal and dexamethasone-induced repression of the murine corticosteroid-binding globulin gene. Mol Cell Endocrinol 1999; 154:29-36.
30. Avvakumov GV, Hammond GL. Glycosylation of human corticosteroid-binding globulin. Differential processing and significance of carbohydrate chains at individual sites. Biochemistry 1994; 33:5759-5765.
31. Bronnegard M, Werner S, Gustaffson JA. Primary cortisol resistance associated with a thermolabile glucocorticoid receptor in a patient with fatigue as the only symptom. J Clin Invest 1986; 78:1270-1278.
32. Chrousos GP, Detera-Wadleigh SD, Karl M. Syndromes of glucocorticoid resistance. Ann Intern Med 1993; 119:1113-1124.